• 11/04/2009

    PAION AG reports results for the first nine months 2009

  • 11/04/2009

    PAION reports positive results of its short acting anaesthetic/sedative CNS 7056 in a Phase IIa study in upper GI endoscopy

  • 10/28/2009

    Phase Ib study endpoint achieved with PAION's short acting anesthetic/sedative CNS 7056

  • 10/12/2009

    Change in PAION AG Management Board

  • 10/06/2009

    PAION announces completion of Phase Ib study with its short acting anesthetic/sedative CNS 7056

  • 10/05/2009

    Abstract on CNS 7056 has been chosen as one of the best abstracts by the American Society Of Anesthesiologists (ASA)

  • 09/08/2009

    PAION to Present at Five Upcoming Conferences

  • 09/08/2009

    PAION Announces Patient Recruitment for Phase IIa Study with its Short Acting Anesthetic/Sedative CNS 7056 Successfully Completed

  • 08/05/2009

    PAION AG reports results for the first half year 2009

  • 07/15/2009

    Phase Ib und IIa Studien mit Anästhetikum/Sedativum CNS 7056 verlaufen nach Plan

  • 05/13/2009

    PAION AG Reports Results for the First Quarter 2009

  • 05/11/2009

    PAION Completes First Part of Phase Ib Study of the anesthetic/sedative CNS 7056

  • 04/20/2009

    PAION Initiates Phase Ib Study of the Anesthetic/Sedative CNS 7056 in Volunteers Undergoing Colonoscopy

  • 04/15/2009

    PAION Initiates Phase II Trial with its Anesthetic/Sedative CNS 7056

  • 04/09/2009

    PAION and ERGOMED report full data of CNS 5161 Phase IIa study in neuropathic cancer pain

  • 03/17/2009

    PAION AG reports consolidated financial results for the fiscal year 2008

  • 01/08/2009

    Press release: PAION's novel sedative/anaesthetic CNS 7056 meets target profile in human proof of concept study